Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Grocery Outlet To Contact Him Directly To Discuss Their Options

The ETF primarily invests in large-cap U.S. stocks. Get 5 stock picks identified before their biggest breakouts, identified by the same system that spotted Insmed, Sprouts, and Uber before their 20%+ gains.

A substantial insider sell was reported on February 25, by Karla R Lewis, President at Reliance RS, based on the recent SEC filing. What Happened: Lewis's decision to sell 31,136 shares of Reliance was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday.

Jody Pollard, Senior Vice President at Rush Enterprises RUSHA, executed a substantial insider sell on February 25, according to an SEC filing. What Happened: Pollard opted to sell 11,250 shares of Rush Enterprises, according to a Form 4 filing with the U.S. Securities and Exchange Commission on ...

BOSTON, Feb. 26, 2025 ( GLOBE NEWSWIRE ) -- Block & Leviton is investigating AppLovin Corporation APP for potential securities law violations. Investors who have lost money in their AppLovin Corporation investment should contact the firm to learn more about how they might recover those losses.

Company's Lottery Retail Ecosystem Makes Impact at Kansas Stores ATLANTA, Feb. 26, 2025 /PRNewswire/ -- Scientific Games' SCiQ retail technology is driving instant scratch game sales and simplifying operations at Kansas Lottery retailers.

Exxon Mobil XOM has outperformed the market over the past 5 years by 1.69% on an annualized basis producing an average annual return of 16.44%. Currently, Exxon Mobil has a market capitalization of $476.39 billion.

Texas Instruments's TXN short percent of float has fallen 6.8% since its last report. The company recently reported that it has 17.52 million shares sold short, which is 1.92% of all regular shares that are available for trading.

Arrow Electronics's ARW short percent of float has fallen 3.06% since its last report. The company recently reported that it has 3.22 million shares sold short, which is 7.92% of all regular shares that are available for trading.

Meeting addressed progress and strategic direction for company's induced mesenchymal stem cell ( iMSC ) therapy programs Meeting addressed progress and strategic direction for company's induced mesenchymal stem cell ( iMSC ) therapy programs ...